| # | Drug | Count |
|---|---|---|
| 0 | IMMUNE GLOBULIN | 2 |
| 1 | OBINUTUZUMAB | 2 |
| 2 | VENETOCLAX | 2 |
| 3 | ALLOPURINOL | 1 |
| 4 | AZITHROMYCIN DIHYDRATE | 1 |
| 5 | BOSUTINIB | 1 |
| 6 | GABAPENTIN | 1 |
| 7 | SILDENAFIL CITRATE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OBINUTUZUMAB | 2 | 0.0001 |
| 1 | BOSUTINIB | 1 | 0.0001 |
| 2 | VENETOCLAX | 2 | 0.0000 |
| 3 | AZITHROMYCIN DIHYDRATE | 1 | 0.0000 |
| 4 | SILDENAFIL CITRATE | 1 | 0.0000 |
| 5 | ALLOPURINOL | 1 | 0.0000 |
| 6 | GABAPENTIN | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | BCL-2 Inhibitor [EPC] | 2 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 2 |
| 2 | Human Immunoglobulin G [EPC] | 2 |
| 3 | Xanthine Oxidase Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 1 | BCL-2 Inhibitor [EPC] | 2 | 0.0000 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 2 | 0.0000 |
| 3 | Xanthine Oxidase Inhibitor [EPC] | 1 | 0.0000 |